Traders should monitor for pricing and launch of the IPO in the coming days, as effectiveness typically precedes pricing by 1-2 days. The $8.8 million in potential warrant proceeds could improve liquidity for this small-cap medical device firm, but the resale of 16 million shares may create near-term dilution pressure.
Price Chart
Executive Summary
IceCure Medical Ltd.'s F-1 registration statement has become effective, allowing the company to proceed with its IPO. The offering is now live, enabling the sale of up to 16 million ordinary shares, including those issuable upon exercise of Series B and Series C warrants from a March 2026 offering. While the company will not receive proceeds from the resale, it stands to gain $8.8 million if all warrants are exercised.
Key Facts
- F-1 registration statement has become effective as of April 10, 2026
- Enables IPO for IceCure Medical Ltd. (ICCM)
- Up to 16 million ordinary shares registered for resale by selling shareholders
- Shares include those issuable upon exercise of Series B and Series C warrants issued in March 2026
- Company will not receive proceeds from resale but expects $8.8 million if all warrants are exercised
Financial Impact
$8.8 million in potential proceeds to the company if all warrants are exercised; no proceeds from shareholder resale
Risk Factors
- Potential share price pressure from resale of 16 million shares by selling shareholders
- Execution risk around IPO pricing and market reception given small market cap of $26M
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001153 |
| Document: 9999999995-26-001153-index.html | 9999999995-26-001153 |
| Document: 9999999995-26-001153.txt | 9999999995-26-001153 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | 6-K | $1.10 | awaiting T+60 | — | $1.03 (−6.36%) |
Oct 5, 2026 21d ago | 6-K | $1.27 | awaiting T+60 | — | $1.03 (−18.90%) |
Oct 5, 2026 21d ago | 6-K | $1.54 | awaiting T+60 | — | $1.03 (+33.12%) |
Sep 10, 2026 6w ago | 6-K | $2.14 | awaiting T+60 | — | $1.03 (−51.87%) |
Aug 24, 2026 9w ago | 6-K | $2.27 | awaiting T+60 | — | $1.03 (−54.63%) |
Aug 19, 2026 9w ago | EFFECT | $2.52 | awaiting T+60 | — | $1.03 (+59.13%) |
Aug 14, 2026 10w ago | 6-K | $2.82 | awaiting T+60 | — | $1.03 (−63.48%) |
Aug 12, 2026 10w ago | 6-K | $3.11 | awaiting T+60 | — | $1.03 (−66.83%) |
Jul 6, 2026 16w ago | EFFECT | $4.61 $1.59 | ▲ +65.51% | ▲ +67.23% | $1.03 (+77.66%) |
Jun 26, 2026 17w ago | 6-K | $5.26 $1.95 | ▲ +62.93% | ▲ +67.31% | $1.03 (+80.42%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers